Taysha Gene Therapies, Inc.TSHANASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank67
3Y CAGR-2.2%
5Y CAGR+22.8%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-2.2%/yr
Annual compound
5Y CAGR
+22.8%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
2.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$120.27M+20.5%
2024$99.79M+13.5%
2023$87.89M-31.6%
2022$128.53M-25.8%
2021$173.27M+302.9%
2020$43.00M+3756.7%
2019$1.11M-